齊翔騰達(002408.SZ):8萬噸/年甲乙酮擴建項目建成投產
格隆匯4月25日丨齊翔騰達(002408.SZ)公吿稱,公司於2021年6月24日召開的第五屆董事會第十四次臨時會議審議通過了《關於投資擴建甲乙酮裝置的議案》,為進一步增強行業競爭優勢,打造多個單項冠軍產品,通過對現有原材料、產品結構及下游客户和國際市場的綜合考量,公司擬在原有甲乙酮裝置的基礎上進行擴建。
目前,公司投資擴建的8萬噸/年甲乙酮項目生產線已建設完工,裝置流程已全線貫通並順利產出合格產品,實現一次開車成功。該項目投產後,公司甲乙酮產品產能將超26萬噸/年,後續公司將根據裝置運行情況進一步優化相關工藝參數,使裝置儘快達產。
甲乙酮擴建項目的建成投產,有利於進一步擴大公司甲乙酮產品在國內外市場佔有率,保持甲乙酮在同行業的領先優勢,進一步提升公司在行業細分領域內的影響力、競爭力,對公司未來的經營業績將產生積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.